[1] | Akerfiedt M.C and Laybut D.R. (2011). Inhibition of Id1 augments secretion and protects against high fat diet-induced Glucose intolerance. Diabetes; 60(10): 2506- 2514. |
|
[2] | Amos A., McCarty D. and Zimmet P. (1997). The rising global burden of diabetes and its complications: estimates and projections to the year 2010. Diabetic Med.; 14: S1-S85. |
|
[3] | Arablou T., Aryaeian N., Valizadeh M., Shariffi F., Hosseini A and Djalali M. (2014). The effect of ginger consumption on glycemic status, lipid profile and some inflammatory markers in patients with Type 2 diabetes mellitus. International Journal of Food Sciences and Nutrition; 65(4): 515-520. |
|
[4] | Elshater A.A., Salman M.M.A and Moussa M.M.A. (2009) Effect of Ginger extract consumption on levels of blood glucose, lipid profile and kidney functions in alloxan-induced diabetic rats. Egypt Acad. J. Biol. Sci.; 2(1): 153-162. |
|
[5] | Guariguata L., Whiting D.R., Humbleton I., Beagley J., Linnenkamp U and Shaw J.E. (2014). Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Research and Clinical Practice; 103(2): 137-149. |
|
[6] | Islam S and Choi H. (2008). Comparative effect s of dietary ginger and garlic investigated in Type 2 diabetes model of rats. Journal of Medicinal Foods: 11(1): 152-159. |
|
[7] | Kar A., Choudary.B/K and Bandyopadhyay N.G.C. (2003). Comparative evaluation of hypoglycemic activity of some Indian medicinal plants on alloxan-induced diabetic rats. J. Ethnopharmacol; 84: 105-8. |
|
[8] | Magao M., Asai A., Kawahara M., Nakayima Y., Sato Y., Tanimura K., Okajima F., Takaya M., lineshigh fat diet-induced glucose intolerance: Development of two novel mouse lines, selectively bred diet-induced glucose intolerance –prone and resistant. Journal of Diabetes Investigation; 3(3): 245-251. |
|
[9] | Mahluji S., Attari V.E., Mabassori M., Payahoo L., Ostadrahimi A and Golzari S.E.J. (2013). Effect of ginger (Zingiber officinale) on plasma glucose level, HbA1c and insulin sensitivity in type 2 diabetic patients. International Journal of Food Sciences and Nutrition; 64(6): 682-686. |
|
[10] | Mascolo H., Jain R., Jain S.C and Capasso F. (1989). Ethnopharmacologic investigation of ginger. J. Ethnopharmacology; 27: 129-140. |
|
[11] | Mozaffari-Khosravi H., Talaei B., Jalali B-A., Najarzadeh A and Mozayan M.R. (2014). The effect of ginger powder supplementation on insulin resistance and glycemic indices in patients with Type 2 diabetes: A randomized double-blind placebo-controlled trial. Complementary Therapies in Medicine; 22(1): 9-16. |
|
[12] | Nammi S., Sreemantha S and Roufogalis B.D. (2009). Protective effects of ethanolic extract of Zingiber officinale rhizome on the development of metabolic syndrome in high-fat diet-fed rats. Basic and Clinical Pharmacology and Toxicology; 104(5): 366-373. |
|
[13] | Panchal S.K.,Pondyal H.M., Iyer A.M., Nazer R., Alam A., Diwan V., Kauter K., Sermia C., Campbell F., Ward L., Gobe G., Fenning A. and Brown L (2011). High carbohydrate, high fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. Journal of Cardiovascular Pharmacology; 57(1): 51-64. |
|
[14] | Shadli S., Alam M., Haque A., Rokeya B and Ali L. (2014). Anti-hyperglycemic effect of Zingiber officinale Roscoe bark in Streptozotocin –induced Type 2 diabetes model rats. International Journal of Pharmacy and Pharmaceutical Sciences; 6(1): 711-716. |
|
[15] | Sharma M. and Shukla S. (1977). Hypoglycemic effect of ginger. J. Res. Ind. Yoga and Homeop. ; 12: 127-130. |
|
[16] | Singhal P.L and Joshi L.D. (1983). Glycemic and cholesterolemic role ginger and till. J. Scie. Res. Plants Med.; 4:32-4. |
|
[17] | Weidner M.S and Sigwart R. (2000). The safety of ginger extract in the rat. J. Ethnopharmacol; 73: 513-520. |
|
[18] | Wild S., Roglic G., Green A., Sicree R and King H. (2004). Global prevalence of diabetes: Estimates for the year 2000 and projections for 2030. Diabetes Care; 27(5): 1047-1053. |
|
[19] | Zheng T., Shu G., Yang Z., Mo S., Zhao Y and Mei Z. (2012). Anti diabetic effect of total saponins from Entada phaseoloides (L). Merr. In Type 2 diabetic rats. Journal of Ethno pharmacology; 139(3): 814-821. |
|
[20] | Zimmet P., Shaw J and Albert K.G. (2003). Preventing Type 2 diabetes and the dysmetabolic syndrome in the real world: a realistic review. Diabet. Med.; 20: 693-702. |
|
[21] | Zong H., Armoni M., Harel C., Karnielli E and Pessin J, (2012). Cytochrome P-450 CYP2E1 knockout mice are protected against high fat diet-induced obesity and insulin resistance. American Journal of Physiology- Endocrinology and Metabolism; 320: E532-E539. |
|